(Received for publication October 15, 1936) In previous studies (1) it was observed that citrated normal plasma rendered free of cellular elements by Berkefeld filtration, contained a substance which accelerated the clotting time of hemophilic blood. A preliminary report (2) indicated that the clot-promoting substance was associated with a saline soluble globulin fraction, as demonstrated by both in vitro and in vivo studies with hemophilic blood. The present report describes in detail the nature of the latter observations.
Effect of temperature on the coagulation-accelerating substance contained in filtered 1 normal plasma. Citrated normal plasma, which had been passed through a Berkefeld filter was diluted with 0.85 per cent NaCl solution to make one part of 1 Hereafter in this paper the term " filter " will denote passage through the Berkefeld filter.
saline to two parts of plasma. Dilution was used in order to bring out gradations in potency. Separate portions were then kept for a constant time, 16 hours, at 100, 240, 370, and 460 C. Equivalent amounts were added by a standard technique 2 to hemophilic blood and the clotting times noted. A slight turbidity appeared in the portions kept at 370 and 460 C. but there was neither true precipitation nor bacterial growth. There was complete inactivation of the material when kept at 460 C. for sixteen hours. At the lower temperatures there was no essential change.
This study was then amplified to determine the effect of varying times of exposure to certain constant temperatures (Table I) . Again filtered normal plasma was used. It was portioned by sterile technique into different tubes which were kept at 50, 370 and 430 C., respectively, for varying intervals of time. Equivalent amounts of the plasmas so prepared were then tested as before for their coagulation-accelerating power on hemophilic blood. In 48 hours there was slight inactivation of the plasma kept at 370 C. and marked inactivation of that kept at 430 C. After 48 hours a precipitate formed in the plasma kept at 430 C. In this case, however, neither the whole plasma, the supernatant fluid, nor the precipitate dissolved in isotonic saline were found to be potent.
The substance contained in filtered normal plasma which effectively reduces the clotting time of hemophilic blood is thermolabile. Effect of dialysis partitions of filtered normal plasma on the clotting time of hemophilic blood. As a first attempt at isolation of the active component of normal plasma a rough partition was tried by simple dialysis. Normal citrated plasma was passed through a Berkefeld filter and then was allowed to dialyze in cellophane jackets for eight days in jars of distilled water at room temperature. The water was changed twice daily. A white flocculent precipitate collected at the bottom of the jackets. The contents of the jackets were transferred to a test tube and the supernatant fluid removed from the precipitate by centrifugation. The precipitate remaining in the jackets together with that freed by centrifugation from the supernatant fluid was washed several times in distilled water and was then suspended in sufficient 0.85 per cent NaCl solution to give the same volume as that of the supernatant fluid. A sample of the parent filtered plasma was then diluted with saline so that its total volume equalled the combined volumes of the supernatant fluid and of the saline suspension of the precipitate. Comparison of the relative effectiveness of the three fluids was then made by adding 0.03 cc. of each to 2 cc. of hemophilic blood, and the clotting times determined.
The addition either of filtered plasma or of the saline suspension of the precipitate reduced sharply the clotting time of hemophilic blood (Table II) , but the supernatant fluid was virtually ineffective. Chemical determinations of Preparation of globulin substance from plasma by dilution and acidification with CO2. The observations recorded above indicated that a coagulation-accelerating substance was associated with the globulin fraction of plasma. However, the separation by dialysis did not provide complete separation of globulin from albumin, and the method was awkward and impracticable. A more direct method was tried which was similar to that described by Addis (13) in the preparation of "fibrinogen solution," and later by Eagle (8) Acetic acid precipitation was likewise used with fresh, filtered plasma from 2 cases of hemophilia, with yields of 452 and 670 mgm., respectively, per 100 cc. plasma.
In two instances, fresh normal blood was defibrinated by stirring with a glass rod and then centrifuged at 2,000 r.p.m. for one-half hour. The supernatant fluid was removed and passed through a Berkefeld filter. This defibrinated plasma was then subjected to dilution and acidification-the resultant precipitate dried, as above, with a yield of about 500 mgm. per 100 cc. plasma.
All materials were then pulverized and kept dry over calcium chloride in a desiccator. Samples of the dried powders so prepared were tested for their effect on the clotting time of hemophilic blood.
Effect of adding dried globulin substance in vitro to hemophilic blood. Ten milligrams of each dried material were emulsified and then taken up in 2 cc. of 0.85 per cent NaCl. The cloudy suspension was centrifuged at 1,500 r.p.m. for 15 minutes and 0.1 cc. of the clear supernatant fluid of each was tested with 2 cc. of hemophilic blood by standard technique. Table V shows that the globulin substance from normal blood,4 whether prepared from citrated plasma by CO2 or acetic acid precipitation, was optimally effective in reducing the clotting time of hemophilic blood, whereas the hemophilic globulin substance, so prepared, was inert. The globulin substance from defibrinated normal blood, however, did not reduce the clotting time of hemophilic blood. In the process of defibrination the coagulation-accelerating material apparently was pre4The addition to hemophilic blood of dried "globulin substance" prepared from sheep, ox, rabbit, and monkey plasma showed a coagulation-accelerating effect similar to that obtained with the normal human derivative. cipitated with the fibrin. That it was not identical with it, however, may be seen in the following studies. Physiological characteristics of the globulin substance prepared from normal and from hemophilic filtered plasmas. Saline suspensions of the dried globulin substances as prepared in the preceding study, were tested by the method of Howell and Cekada (18) who used a calcium-fibrinogen system in their comparison of normal and hemophilic prothrombin. Calcium chloride was made up in 0.5 per cent aqueous solution. Fibrinogen solution was prepared from normal human blood according to the method of McLean (25) . The addition successively of calcium chloride, of fibrinogen and of both calcium chloride and fibrinogen to a solution of the globulin substance was performed in standard test tubes. The tubes were shaken briefly and placed in a water bath at 370 C.
It was observed that the addition of calcium chloride alone to the globulin substance did not produce clotting. The addition of fibrinogen solution to the globulin substance produced no clot in six hours but did cause clotting in 24 hours. This suggested that the globulin substance, acting as prothrombin, was slowly converted into thrombin, which, as Mellanby (11) has shown, may take place in the presence of minute quantities of calcium or even in its apparent absence.
The addition of both calcium chloride and fibrinogen solutions to solutions of the hemophilic as well as of the normal globulin substance was followed by prompt clotting (Table VI) .
According to the criteria of Howell and Cekada (18) , these observations confirm their conclusions, namely, that quantitatively and physiologically both the normal and hemophilic prothrombins behave similarly. However, when solutions of these globulin substances were tested with hemophilic blood as in the preceding study, only the normal globulin stubstance, unlike the hemophilic, caused a sharp reduction of clotting time.
The clot fonmed by the combination of hemophilic globulin substance with calcium and fibrinogen reliquefied in 12 hours, whereas the clot formed by combination with normal globulin substance reliquefied only after 24 to 48 hours.
In filtered normal plasma, after dilution with water and acidification with either CO2 to pH 5.9 or with 1 per cent acetic acid to pH 5.3, there was formed a precipitate which, dried in vacuo, contained an active coagulation-promoting substance for hemophilic blood. Approximately 500 to 700 mgm. of the grey powder were obtained from 100 cc. of citrated normal plasma.
When the above procedure was applied to hemophilic plasma an approximately equivalent amount of dried material was produced, the saline suspension of which had little, if any, ability to hasten the clotting of hemophilic blood in the test tube.
Tested against a freshly prepared calcium fibrinogen system, both the normnal and hemophilic precipitates were equally active as prothrombin. These observations seem to indicate that the difference between normal and hemophilic blood is due either to a qualitative difference of the globulin substance or to other substances associated with the globulin fraction of the plasma.
The effect of reprecipitation of the globulin substance contained in normal plasma. After precipitating globulin substance from filtered normal plasma by dilution and acidification to pH 5.3, the precipitate was taken up in 0.85 per cent NaCl to the volume of the parent plasma. This saline suspension of globulin was centrifuged at 2,500 r.p.m. for one-half hour in order to rid the mixture of particulate matter. The supernatant fluid was then diluted with 10 volumes of water, and a white flocculent precipitate was thrown down at pH 5.3. The precipitate was collected and dried in a vacuum desiccator. The yield of reprecipitated globulin substance was 430 mgm. per 100 cc. of plasma. When equivalent concentrations of the reprecipitated globulin substance were compared with the preparations obtained by a single precipitation, the reprecipitated globulin substance was found to be less active than the cruder material in its clot-promoting power on hemophilic blood. Refinement and concentration by this method, therefore, was unsuccessful.
The chemical characteristics of globulin substance. Globulin substance prepared from normal plasma gives the usual precipitation and color reactions of a protein, and the specific reactions of globulin. It is partially soluble in 0.85 per cent NaCl solution but wholly insoluble in distilled water at pH 6 globulin substance prepared from plasma of different subjects is given in Table VII . The values are in terms of the percentage of nitrogen dissolved in isotonic saline. Globulin substance from two normal individuals and from a patient with hemophilia whose blood clotted in between 40 and 60 minutes was found to be 50 to 60 per cent soluble in 0.85 per cent NaCl solution. Globulin substance from a case of hemophilia in which the clotting time was above 2 hours was 16 per cent soluble. Normal globulin substance reprecipitated from its saline solution showed a reduced solubility to 29 per cent in 0.85 per cent NaCl solution. Further studies are essential in order to determine whether these differences are due to intrinsic peculiarities of the globulin substances or whether they are due to unintentional variations in the technique of preparation.
The coagulation-accelerating substance obtained from normal plasma is precipitated with a protein giving the characteristics of a saline soluble globulin.
Effect of variation in temperature on the coagulation-accelerating power of globulin substance obtained from filtered normal plasma. One hundred mgm. of powdered globulin substance from normal blood was taken up in 20 cc. of 0.85 per cent NaCl solution. The insoluble matter was centrifuged down, and the clear supernatant fluid was pipetted by sterile technique into each of five tubes. Each tube was then kept at a different constant temperature. At intervals, 0.1 cc. of each fluid was removed from the tubes and tested in the usual manner against 2 cc. of hemophilic blood, and the clotting times noted with standard technique. All fluids remained clear except for those kept at 48°C ., which acquired a flocculent precipitate after one-half hour.
It was observed (Table VIII, Figure 1 ) that at 480 C. there was loss of activity in 3 to 6 hours; at 43°C., in 6 to 10 hours; at 36°C. in 10 hours; at 250 C. in 22 hours; at 100 C. a slight loss in 48 hours. Like plasma, the coagulation-accelerating activity of globulin substance is thermolabile.
Observations on the optimital hydrogen ionI concentration for the precipitation of active globulin substance. Since active globulin substance from normal plasma was obtained by precipitation either 12 11 minutes and the clear, supernatant fluid tested by standard technique against hemophilic blood. It was noted that the substance obtained by precipitation at pH 5.9 to pH 6.4 was the most effective in reducing the clotting time of hemophilic blood (Table X; Figure 2 ). While only one set of observations is recorded, the procedure has been repeated with practically identical results.
The effect of dilution on the activity of dried globulin substance obtained from normal filtered plasma. Fifty mgm. of dried globulin substance precipitated at the optimal point of pH 6.09 was taken up in 5 cc. of 0.85 per cent NaCl solution. After thorough mixture, this was centrifuged at 2,000 r.p.m. for 15 minutes, and the clear, super- Table XI and Figure 3 , the effect of dilution upon the coagulation-accelerating activity of the globulin substance from normal plasma is illustrated.
By increased concentration of globulin substance 15 minutes, approximately 0.5 gram was recovered, indicating that about 50 per cent was soluble. The supernatant fluid was passed through a Berkefeld filter (Grade V) and administered by gravity infusion as described previously. The procedure was performed in 3 cases. When injected in about 10 minutes, the patients experienced a sensation of fullness and warmth. In two instances the injection was followed in 1 hour by moderate chill and headache for 10 minutes. In the third instance, when the material was injected during a period of 30 minutes, no untoward reaction occurred.
There followed in each case a definite reduction of clotting time (Table XII and Figure 4 ) which was sustained for 10 hours in 2 cases and for 24 hours in the third. The response was slower than that occurring after blood transfusion (1) . The material used in Case II was freshly prepared (12) applied the principle of adsorption with tricalcium phosphate for the preparation from plasma of proserozyme (prothrombin). Addis (13) and later Eagle (8) precipitated it by dilution of plasma with water and acidification with CO2. Howell (4) obtained it by acetone precipitation of plasma. Because of the varied methods for preparation and the failure to obtain a pure substance there is not complete agreement over the properties of prothrombin. In general, it is thought to be a protein, of globulin nature, nondialyzable, insoluble in distilled water but soluble in weak alkali. Its reaction to changes of temperature have been variously described.
A number of communications have attributed the clotting abnormality of hemophilia to altered prothrombin. Addis (13), Christie and his coworkers (6), Feissly and Fried (14) believed the delayed clotting resulted from a qualitative change in this substance. Klinger (15) , Hurwitz and Lucas (16) , and Howell (17) said there was a quantitative defect, but the latter reversed his opinion later (18) . Govaerts and Gratia (19) concluded that a dual mechanism was involved, namely, that a plasma factor in normal blood activated the abnormally stable hemophilic platelets. The plasma factor was neither proserozyme (prothrombin) nor cytozyme (thrombokinase).
The present studies, we believe, clarify in a measure this confusion. If a scheme for blood clotting is accepted that involves only prothrombin, calcium, and fibrinogen, both normal and hemophilic prothrombins function similarly.
However, the addition of normal prothrombin accelerates the clotting of hemophilic blood, whereas the addition of hemophilic prothrombin does not. Hence, regardless of its behavior in a calcium fibrinogen system, there must be a specific alteration in the hemophilic "prothrombin complex."
The clotting substance described here is not dialyzable, but it does pass through a Berkefeld filter. Its range of optimal precipitation from plasma lies between pH 5.9 and 6.4. It is thermolabile, insoluble in water at pH 6.5, but soluble in isotonic saline. The substance so obtained either gives reactions of a protein with the characteristics of globulin or is associated with such a material. However, hemophilic plasma yields a similar material which has only minimal coagulation-accelerating activity. Therefore, one may conclude at this juncture only that the clotting substance is precipitated with globulin, but there is no proof that it is globulin itself.
Reiner and Reiner (20) have shown that there are at least two serum globulins with precipitation points at pH 5.1 and 6.8 respectively. It is possible that the hemophilic abnormality is associated with only one of several globulins. It is also possible that the active principle in globulin substance is an enzyme. Its possible protein nature, its potency in small amount, its pattern of reaction to changes in temperature and to dilution, its specific range of precipitation from plasma invite such an hypothesis.
Heretofore, the clotting abnormality of hemophilia has been studied in vitro. Bendien and Creveld (21, 22) implied that in vivo studies with a substance they isolated were promising, but no data were given. The fact that normal globulin substance reduces the clotting time in vivo, we believe changes the complexion of the disease from an abnormality that was immutably fixed to one that is amenable to change. Likewise the preparation of a relatively stable dry substance makes practical the further study of its properties.
Since the exact nature of globulin substance is not definable, comparison with other substances that are said to be active coagulation-accelerators in hemophilia would be untimely. Recent studies with vitamin K (23) may provide analogies. The placental coagulant described by Eley and his coworkers (24) may contain globulin sub-stance since placenta is rich in blood. However, in several respects the two substances differ.
More closely similar appears to be that described by Bendien and his coworkers (21) in Holland.
Obviously much remains to be learned: a more exact definition of "globulin substance "; its metabolism; its relation, if any, to enzymic processes; and ultimately its relation, if any, to the peculiar sex linkage that characterizes the disease.
SUMMARY AND CONCLUSIONS 1. Upon dilution and acidification of filtered normal plasma there is formed a globulin precipitate, which, either fresh or dried in vacuo, contains a clot-promoting substance for hemophilic blood. This substance is effective both in vitro and in vivo.
2. When the above procedure is applied to hemophilic plasma an approximately equivalent amount of precipitate is formed, the saline suspension of which has very little ability to hasten the clotting of hemophilic blood.
3. Tested with a calcium-fibrinogen system both normal and hemophilic precipitates are equally active as " prothrombin."
4. In respect to clotting activity " globulin substance" so prepared from normal plasma is thermolabile, insoluble in water at pH 6.5, but soluble in isotonic saline. It is not ultrafilterable, but it does pass through a Berkefeld filter. Its range of optimal precipitation from plasma is between pH 5.9 and 6.4.
